Tarsus Pharmaceuticals Inc Long-term Investment Intensity
Tarsus Pharmaceuticals Inc long-term investment intensity. Tarsus Pharmaceuticals Inc (TARS) has a Long-term Investment Intensity of 1.1% as of June 2026. Long-term investments of $6.68 Million represent 1.1% of total assets of $611.14 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See TARS net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Tarsus Pharmaceuticals Inc (2022–2025)
Long-term investment intensity of Tarsus Pharmaceuticals Inc from 2022 to 2025. This chart shows how Tarsus Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 4 annual periods from 2022 to 2025. As of June 2026, the intensity stands at 1.1%, reflecting long-term investments of $6.68 Million against total assets of $611.14 Million USD. See Tarsus Pharmaceuticals Inc (TARS) defensive interval to measure how many days the company can operate on defensive assets alone.
Tarsus Pharmaceuticals Inc Long-term Investment Intensity by Year (2022–2025)
Tarsus Pharmaceuticals Inc long-term investment intensity by year from 2022 to 2025. The table below presents the year-by-year Long-term Investment Intensity for Tarsus Pharmaceuticals Inc from 2022 to 2025, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Tarsus Pharmaceuticals Inc (TARS) total assets.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 0.7% | $3.87 Million | $562.16 Million | ▼ -0.1 pp |
| 2024 | 0.8% | $3.00 Million | $376.99 Million | ▲ +0.6 pp |
| 2023 | 0.2% | $631.00K | $265.49 Million | ▲ +0.1 pp |
| 2022 | 0.2% | $371.00K | $227.86 Million | — |